Pharma & Bio
Technology
A Hurdle Even AeroSpace Technology of Korea, Inc. and Roche Couldn’t Clear… J2H Takes a Gamble on MASH with ‘Cortisol’
(Image: ChatGPT.)
While glucagon-like peptide-1 (GLP-1) drugs—treatments for obesity and metabolic disorders—have become the dominant trend as the biggest issue in the global pharmaceutical and bi…
Technology
"70% of Last Year's Revenue in Just Half a Year"... Will IVIM Technology, Inc. Be Able to Turn Things Around Next Year?
#IVIM Technology, Inc. is poised for a turnaround in its financial performance. In the first half of this year alone, the company achieved revenue approaching 70% of last year’s total, demonstrating r…
Lifestyle
Mezzion Pharma Co., Ltd. Sets Separate “Price Tag” for New Kidney Disease Drug… Establishes U.S. Subsidiary with an Eye Toward M&A
Mezzion Pharma Co., Ltd.(140410)has established an additional U.S. subsidiary dedicated exclusively to the development of treatments for autosomal dominant polycystic kidney disease (ADPKD).According …
Technology
SK Bioscience Completes Phase 1 Trials for Its First mRNA Vaccine… Reasons for Caution in Moving to Phase 2
#SK Bioscience has completed the global Phase 1 clinical trial for “GBP560,” a Japanese encephalitis vaccine candidate currently under development using messenger ribonucleic acid (mRNA) technology. A…
Technology
“Beyond VEGF Inhibition to Vascular Normalization”… Ingenia and curacle co., ltd. Compete in TIE2 Therapy for Age-Related Macular Degeneration
The focus of research into treatments for wet age-related macular degeneration is broadening from preventing abnormal blood vessel formation to stabilizing the damaged blood vessels themselves. This a…
Technology
[Big Tech Enters New Drug Development] 2.9 Trillion vs. 16 Billion… Success of South Korean AI-Driven New Drugs Depends on “Stamina,” Not Algorithms
Isomorphic Labs, a spin-off from Google DeepMind, raised approximately 2.9 trillion won in a single funding round last May. During the same period, the Series B funding round for a leading South Korea…
Technology
[Big Tech Enters New Drug Development: Part 1] Google Becomes First Big Tech Company to Conduct 'In-House Clinical Trials'… Will This Shake Up the New Drug Development Landscape?
Isomorphic Labs, a spin-off from Google DeepMind, is reportedly on the verge of entering the first human clinical trial for a new cancer drug designed using artificial intelligence (AI). If successful…
Business·Industry
Cellid and BlueMtec Rally on Change-of-Control Deals; Inventera Gains [K-bio pulse]
On September 22, changes in control at biotech companies drew significant attention across South Korea’s pharmaceutical and biotech sectors. Vaccine developer Cellid surged after announcing a deal wit…
Business·Industry
Cellid Co., Ltd. and BLUEMTEC CO., LTD. See Volatility on News of Management Control Sale… Inventera Inc. Rises [Bio Spotlight]
On the 22nd, news of management control sales by biotech companies drew significant attention in the pharmaceutical and biotech industry. Shares of vaccine developer Cellid Co., Ltd. surged after it a…
Technology
Japanese Stroke AI Expert: "Korean Medical AI Technologies, Such as JLK, Inc., Play a Major Role in Japan"
"I was impressed by South Korea's AI medical technology. If accurate, clear, and objective indicators are automatically provided, it could significantly reduce the burden on medical staff in the treat…